These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study. Keck PE; Orsulak PJ; Cutler AJ; Sanchez R; Torbeyns A; Marcus RN; McQuade RD; Carson WH; J Affect Disord; 2009 Jan; 112(1-3):36-49. PubMed ID: 18835043 [TBL] [Abstract][Full Text] [Related]
25. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Keck PE; Versiani M; Potkin S; West SA; Giller E; Ice K; Am J Psychiatry; 2003 Apr; 160(4):741-8. PubMed ID: 12668364 [TBL] [Abstract][Full Text] [Related]
26. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania. McElroy SL; Martens BE; Winstanley EL; Creech R; Malhotra S; Keck PE J Affect Disord; 2010 Jul; 124(1-2):157-63. PubMed ID: 19963274 [TBL] [Abstract][Full Text] [Related]
27. In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder. Jahangard L; Soroush S; Haghighi M; Ghaleiha A; Bajoghli H; Holsboer-Trachsler E; Brand S Eur Neuropsychopharmacol; 2014 Aug; 24(8):1210-21. PubMed ID: 24953766 [TBL] [Abstract][Full Text] [Related]
28. Lithium for acute mania. McKnight RF; de La Motte de Broöns de Vauvert SJGN; Chesney E; Amit BH; Geddes J; Cipriani A Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004048. PubMed ID: 31152444 [TBL] [Abstract][Full Text] [Related]
29. Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder. Weiser M; Burshtein S; Gershon AA; Marian G; Vlad N; Grecu IG; Tocari E; Tiugan A; Hotineanu M; Davis JM Bipolar Disord; 2014 Jun; 16(4):441-7. PubMed ID: 24712840 [TBL] [Abstract][Full Text] [Related]
30. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Keck PE; Marcus R; Tourkodimitris S; Ali M; Liebeskind A; Saha A; Ingenito G; Am J Psychiatry; 2003 Sep; 160(9):1651-8. PubMed ID: 12944341 [TBL] [Abstract][Full Text] [Related]
31. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. Weisler RH; Kalali AH; Ketter TA; J Clin Psychiatry; 2004 Apr; 65(4):478-84. PubMed ID: 15119909 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study. Vieta E; T'joen C; McQuade RD; Carson WH; Marcus RN; Sanchez R; Owen R; Nameche L Am J Psychiatry; 2008 Oct; 165(10):1316-25. PubMed ID: 18381903 [TBL] [Abstract][Full Text] [Related]
33. A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states. McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J Bipolar Disord; 2009 Nov; 11(7):673-86. PubMed ID: 19839993 [TBL] [Abstract][Full Text] [Related]
35. The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial. Durgam S; Starace A; Li D; Migliore R; Ruth A; Németh G; Laszlovszky I Bipolar Disord; 2015 Feb; 17(1):63-75. PubMed ID: 25056368 [TBL] [Abstract][Full Text] [Related]
36. Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder. Post RM; Altshuler LL; Frye MA; Suppes T; McElroy SL; Keck PE; Leverich GS; Kupka R; Nolen WA; Luckenbaugh DA; Walden J; Grunze H J Clin Psychiatry; 2005 Mar; 66(3):370-4. PubMed ID: 15766304 [TBL] [Abstract][Full Text] [Related]
37. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609 [TBL] [Abstract][Full Text] [Related]
38. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495 [TBL] [Abstract][Full Text] [Related]
39. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Hirschfeld RM; Keck PE; Kramer M; Karcher K; Canuso C; Eerdekens M; Grossman F Am J Psychiatry; 2004 Jun; 161(6):1057-65. PubMed ID: 15169694 [TBL] [Abstract][Full Text] [Related]
40. Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension. Szegedi A; Calabrese JR; Stet L; Mackle M; Zhao J; Panagides J; J Clin Psychopharmacol; 2012 Feb; 32(1):46-55. PubMed ID: 22198448 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]